Minnesota medtech accelerator debuts, with Medtronic vet at the helm

An executive with R&D experience from Medtronic ($MDT) is co-launching Inceptis, a new medtech accelerator based in Minnesota. Daniel Sigg served as senior research manager at Medtronic a few years back and has also served in executive roles at various life sciences companies, according to his LinkedIn profile. Devicix, a product development and engineering firm, is also an equal partner in the enterprise, MedCity News reports. Inceptis will focus on Class II medical devices and plans to begin raising between $10 million and $14 million in the fall, according to the article. Story

Suggested Articles

About 10 months after first announcing the move, Google has finally subsumed the healthcare-focused efforts of DeepMind.

Amgen has tapped Adaptive Biotechnologies to deliver next-generation sequencing assays as it moves its blood cancer drugs toward approval.

Bayer led One Drop’s $40 million series B round and licensed its technology for its “bio-digital efforts” in areas such as cancer and heart disease.